114 related articles for article (PubMed ID: 17851253)
1. Matrix metalloproteinase-2 promoter polymorphism is associated with breast cancer in a Mexican population.
Delgado-Enciso I; Cepeda-Lopez FR; Monrroy-Guizar EA; Bautista-Lam JR; Andrade-Soto M; Jonguitud-Olguin G; Rodriguez-Hernandez A; Anaya-Ventura A; Baltazar-Rodriguez LM; Orozco-Ruiz M; Soriano-Hernandez AD; Rodriguez-Sanchez IP; Lugo-Trampe A; Espinoza-Gomez F; Michel-Peregrina ML
Gynecol Obstet Invest; 2008; 65(1):68-72. PubMed ID: 17851253
[TBL] [Abstract][Full Text] [Related]
2. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
Xu E; Lai M; Lv B; Xing X; Huang Q; Xia X
Biochem Biophys Res Commun; 2004 Nov; 324(3):999-1003. PubMed ID: 15485653
[TBL] [Abstract][Full Text] [Related]
3. A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma.
Miao X; Yu C; Tan W; Xiong P; Liang G; Lu W; Lin D
Cancer Res; 2003 Jul; 63(14):3987-90. PubMed ID: 12873995
[TBL] [Abstract][Full Text] [Related]
4. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].
Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216
[TBL] [Abstract][Full Text] [Related]
5. Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer.
Yu C; Pan K; Xing D; Liang G; Tan W; Zhang L; Lin D
Cancer Res; 2002 Nov; 62(22):6430-3. PubMed ID: 12438229
[TBL] [Abstract][Full Text] [Related]
6. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
Vasků A; Goldbergová M; Izakovicová Hollá L; Sisková L; Groch L; Beránek M; Tschöplová S; Znojil V; Vácha J
Matrix Biol; 2004 Jan; 22(7):585-91. PubMed ID: 14996438
[TBL] [Abstract][Full Text] [Related]
7. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.
Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D
Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291
[TBL] [Abstract][Full Text] [Related]
8. Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.
Zhou Y; Yu C; Miao X; Tan W; Liang G; Xiong P; Sun T; Lin D
Carcinogenesis; 2004 Mar; 25(3):399-404. PubMed ID: 14604886
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-2 promoter variability in psoriasis.
Vasku V; Bienertova Vasku J; Slonková V; Kanková K; Vasku A
Arch Dermatol Res; 2009 Jul; 301(6):467-73. PubMed ID: 19360430
[TBL] [Abstract][Full Text] [Related]
10. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype.
Grieu F; Li WQ; Iacopetta B
Breast Cancer Res Treat; 2004 Dec; 88(3):197-204. PubMed ID: 15609121
[TBL] [Abstract][Full Text] [Related]
12. Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis.
Lin SC; Lo SS; Liu CJ; Chung MY; Huang JW; Chang KW
J Oral Pathol Med; 2004 Aug; 33(7):405-9. PubMed ID: 15250832
[TBL] [Abstract][Full Text] [Related]
13. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-2 C(-1306)T promoter polymorphism and breast cancer risk in the Saudi population.
Saeed HM; Alanazi MS; Alshahrani O; Parine NR; Alabdulkarim HA; Shalaby MA
Acta Biochim Pol; 2013; 60(3):405-9. PubMed ID: 24051440
[TBL] [Abstract][Full Text] [Related]
15. [Polymorphism of gene promotor region for MMP-2 in rheumatoid arthritis].
Nemec P; Goldbergová M; Swobodnik T; Polásková D; Soucek M; Vasků A
Vnitr Lek; 2006 Apr; 52(4):348-54. PubMed ID: 16755991
[TBL] [Abstract][Full Text] [Related]
16. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
Tasci AI; Tugcu V; Ozbek E; Ozbay B; Simsek A; Koksal V
BJU Int; 2008 Feb; 101(4):503-7. PubMed ID: 17986285
[TBL] [Abstract][Full Text] [Related]
17. An association between the matrix metalloproteinase 1 promoter gene polymorphism and lymphnode metastasis in breast cancer.
Przybylowska K; Zielinska J; Zadrozny M; Krawczyk T; Kulig A; Wozniak P; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
J Exp Clin Cancer Res; 2004 Mar; 23(1):121-5. PubMed ID: 15149160
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis.
Benesová Y; Vasků A; Stourac P; Hladíková M; Beránek M; Kadanka Z; Novotná H; Bednarík J
J Neuroimmunol; 2008 Dec; 205(1-2):105-9. PubMed ID: 18835646
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression.
Hughes S; Agbaje O; Bowen RL; Holliday DL; Shaw JA; Duffy S; Jones JL
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6673-80. PubMed ID: 18006768
[TBL] [Abstract][Full Text] [Related]
20. The matrix metalloproteinase-21 gene 572C/T polymorphism and the risk of breast cancer.
Shagisultanova EI; Novikova IA; Sidorenko YS; Marchenko GN; Strongin AY; Malkhosyan SR
Anticancer Res; 2004; 24(1):199-201. PubMed ID: 15015597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
